Nrf2 pathway | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,635 results for “Nrf2 pathway”

Trials

View all 1707 →

Broccoli Sprout Extracts in Healthy Volunteers: A Pilot Study of Nrf2 Pathway Modulation in Oral Mucosa

10 participants · First posted Dec 30, 2013

The Mechanism of lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome Through miR-27b Regulated Nrf2 Pathway

425 participants · First posted Jun 24, 2021

ITMCTR2100005469

Transcutaneous acupoint electrical stimulation improves postoperative sleep of patients with gastrointestinal tumors by regulating the Nrf2/ARE signal pathway

Drugs

View all 98 →

Nrf2 inhibitors (cancer)

Nrf2/ARE activators

UPR pathway modulators (Proteostasis)

Organizations

View all 14 →

Pathway Therapeutics, Inc.

United States

Erasca

United States

Eledon Pharmaceuticals

United States

News

View all 4816 →

ACS Fall 2024: Novel Small Molecules in Clinical Development Unveiled

AnnJi Pharmaceutical Reports Promising Phase 1/2a Results for AJ201 in SBMA, a Rare Neuromuscular Disease

New Therapeutic Targets and Immunotherapy Approaches Emerge for Cerebral Small Vessel Disease

Page 1 of 664